abstract |
Antisense compounds, compositions and methods are provided for inhibiting the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for inhibition of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided. |